The biological role of truncated insulin-like growth factor-1 and the tripeptide GPE in the central nervous system.
Sara
V R
VR
Karolinska Institute's Department of Pathology, Karolinska Hospital, Stockholm, Sweden.
Carlsson-Skwirut
C
C
Drakenberg
K
K
Giacobini
M B
MB
Håkansson
L
L
Mirmiran
M
M
Nordberg
A
A
Olson
L
L
Reinecke
M
M
Ståhlbom
P A
PA
D000595:Amino Acid Sequence; D000818:Animals; D001667:Binding, Competitive; D002490:Central Nervous System / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000737:chemistry / Q000494:pharmacology* / Q000502:physiology*; D008959:Models, Neurological; D008969:Molecular Sequence Data; D009474:Neurons / Q000187:drug effects / Q000502:physiology*; D009842:Oligopeptides / Q000494:pharmacology*; D017433:Protein Structure, Secondary; D017526:Receptor, IGF Type 1 / Q000378:metabolism*
D009842:Oligopeptides; D007334:Insulin-Like Growth Factor I; D017526:Receptor, IGF Type 1; C062053:glycyl-prolyl-glutamic acid